Assessing signal transduction, we observed that the inhibition of Erk1/2 MAPK reduced ICAM1 stimulation by RV in BEC of asthma patients and controls but not COPD patient (Fig 6B). This evidence concerns the gene ICAM1 and chronic obstructive pulmonary disease.